Current Opinion in HIV and AIDS was launched in 2006. It is one of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The fields of HIV and AIDS are divided into 12 sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Section Editors for this issue.
Professor Christine Katlama is Professor of Infectious Diseases and Head of the AIDS Clinical Research Unit in the Department of Infectious Diseases at the Pitié-Salpêtrière Hospital in Paris, France. She is president of the COREVIH Ile de France Centre which gathers three important hospitals in Paris (Pitié Salpetriere, Saint-Antoine and Tenon).
Professor Katlama has worked in the field of HIV since 1982 and was involved in the discovery of HIV-2 in 1986. Her group first demonstrated the impact of HAART on immune reconstitution and works extensively in the field of new drugs and resistance. Professor Katlama is a founder member of ORVACS, which is developing a therapeutic vaccination program for HIV-infected patients. As President and founder of SOLTHIS, a non-governmental organization, she is heavily involved in access to HIV treatment and education in developing countries. Professor Katlama was president of EACS until July 2004, and remains an active member, involved in many educational initiatives. She is a member of the editorial boards of several journals including HIV Medicine and AIDS.
Paul E. Sax
Dr Paul E Sax is Clinical Director of the Division of Infectious Diseases and the HIV Program at Brigham and Women's Hospital (BWH), Boston, USA. He has been on the faculty at Harvard Medical School since 1992, where he is currently an Associate Professor of Medicine. Dr Sax received his MD from Harvard Medical School in 1987. He served his residency in Internal Medicine at BWH, while continuing his postdoctoral education with a fellowship in the Infectious Disease Unit of Massachusetts General Hospital. Dr Sax is board certified in internal medicine and infectious diseases. He is Editor-in-Chief of Journal Watch: AIDS Clinical Care, is on the peer review board of the HIV/AIDS Section of UpToDate, and the editorial board of Medscape HIV/AIDS. Dr Sax is also on the core faculty of the International AIDS Society - USA and the New England AIDS Education and Training Center. In addition to his clinical and teaching work, Dr Sax is actively involved in HIV research. Ongoing areas of research interest include clinical trials of antiretroviral therapies, cost-effectiveness of management strategies for HIV, and toxicity of antiretroviral therapy. He is presently the principal investigator at the BWH AIDS Clinical Trials Unit, and is a member of the Cost-Effectiveness of Preventing AIDS Complications (CEPAC) Research Group.